Today's Optometrists Basic Laser Principles Anterior Segment

Total Page:16

File Type:pdf, Size:1020Kb

Today's Optometrists Basic Laser Principles Anterior Segment 11/16/2017 Professional Disclosures • Alcon: Advisory Board, Consultant, Research, Speaker Laser Applications in • Allergan: Advisory Board, Research, Speaker • Bausch & Lomb: Advisory Board, Research, Speaker Clinical Optometry • Beaver Visitec: Consultant COPE ID: 49115-LP • Biotissue: Advisory Board, Speaker Walter O. Whitley, OD, MBA, FAAO • Ocusoft: Advisory Board Director of Optometric Services • Science Based Health: Advisory Board, Speaker Virginia Eye Consultants • Shire: Advisory Board, Speaker Residency Program Supervisor • Sun Pharmaceuticals: Advisory Board PCO at Salus University • TearLab Corporation: Advisory Board • Tearscience: Speaker Virginia Eye Consultants Tertiary Referral Eye Care Since 1963 Today’s Optometrists • John D. Sheppard, MD, MMSc • Walter Whitley, OD, MBA, FAAO • Stephen V. Scoper, MD • Cecelia Koetting, OD, FAAO • David Salib, MD • Chris Kruthoff, OD, FAAO “To be on the cutting edge of optometry, • Elizabeth Yeu, MD • Jessica Schiffbauer, OD you need to be on the cutting edge of • Thomas J. Joly, MD, PhD • Kelsey Butler, OD science and technology” • Dayna M. Lago, MD • Constance Okeke, MD, MSCE • Jay Starling, MD • Samantha Dewundara, MD Basic Laser Principles Anterior Segment Applications • Photodisruption – YAG Laser, Femto • YAG Laser Posterior Capsulotomy • Phototherapeutic Keratectomy • Photoablation – PRK • Corneal Transplantation • Corneal Crosslinking??? • Photocoagulation - PRP • Intense Pulse Light???? 1 11/16/2017 YAG Capsulotomy What Do Patient’s Want to Know? • Indications • What is it? – Decreased visual acuity – Reduced contrast sensitivity • Why did I get it? – Increased glare – Poor view of fundus • How is it treated? – Small anterior capsulorhexis – PAM shows improved acuity • ATIOL Considerations YLC Contraindications Does the BCVA Make Sense? • Corneal scarring /edema that prevents a clear view during the procedure • Placement of a glass intraocular lens during cataract surgery • Presence of iritis • Macular edema • Previous retinal tears or detachments • Early postoperative period • Glaucoma patients YLC Procedure Follow Up • Dilation • 90 day global period • Apraclonidine 1% • Consider medications – inflammation/IOP • Power setting • Check refraction – Mild haze - 0.8 mJoules – Moderate haze – 1.5 mJoules • IOP – Dense haze – 2.2 mJoules • Presence of inflammation • Q-switched vs. mode-locked • Dilation • Focus just deep to the capsule/IOL interface • Anything else? • Create window through posterior capsule 2 11/16/2017 YLC Complications Refractive Surgery Applications • Transient intraocular pressure elevation • LASIK • Iritis • PRK • Retinal tears and detachments • Cataract Surgery • Macular edema • Lenticule Extraction • Corneal edema • Intrastromal Corneal • Intraocular lens dislocation into the vitreous Reshaping • Pitting of the intraocular lens • Corneal inlays • Lens Bleaching High Patient Expectations in Cataract Refractive Surgery The Femto Phaco Market Cataract Outcomes*** • Patient expectations are at an all-time 100% high for refractive surgery 90% 97% • Positive experiences with LASIK have 80% produced high expectations, at a 70% minimum achieving: 71% 60% – 92.6% of LASIK patients with vision of 20/40 or better* 50% – 95.4% of patients satisfied with their 40% outcome after LASIK surgery** 41% 30% • Cataract surgery outcomes may not 20% be meeting the target of ±0.5D that is considered the standard 10% 0% ±0.25D ±0.5D ±1.0D *“LASIK Surgery Statistics.” Docshop.com. http://www.docshop.com/education/vision/refractive/lasik/statistics **Solomon, K et al. (2009) “LASIK world literature review: quality of life and patient satisfaction.” Ophthalmology. 16(4):691-701 ***Graph: Data from Dr. Warren Hill & Behndig A, et al. Aiming for emmetropia after cataract surgery: Swedish National Cataract Register study. J Cataract Refract Surg. 2012;38(7):1181-6. 8/13 VRN13066SK 16 Limitations of Traditional Traditional Cataract Surgery: Cataract Surgery Common Complications • 10-40% Posterior capsule opacification • 2-12% Transient cystoid macular edema • 4-10% Corneal endothelial cell loss • 1-5% Vitreous prolapse or loss • 1-2% Persistent cystoid macular edema • 0.6-2% Retinal detachment • 0.3% IOL Malposition • 0.3% Consecutive corneal transplantation • 0.1% Endophthalmitis 7 3 11/16/2017 Improved Refractive Quality = Safety Cataract Surgery • Fewer Wound Leaks • Address Major Requirements for Improved Refractive • Lower Endophthalmitis Rates Procedure • Fewer Corneal Abrasions, Less PO Pain • More Predictable PO Astigmatism • LRIs arcuate & without induced Dry Eye IOL Position Corneal Early Wow Factor • Less IOL Decentration & IOL Tilt Predictability Astigmatism • Reduced Phaco • Fewer YAG Capsulotomies • Uniform Shape and • Reproducible Power and Corneal • Less Phaco Time Size Capsulotomy Corneal Entry and Edema Arcuate Incisions • Fewer Ruptured Posterior Capsules Norrby SJ, J Cataract Refract Hill WJ, J Cataract Refract Devgan U, Current Opinions in Surg 2008;34:368–376 Surg 2008;34:364–367 Ophthalmology 2011;18:19–22. • Lower Endothelial Cell Loss 8 Manual Clear Corneal Incisions Laser Corneal Incisions • Dynamics of wound architecture created with hand- held instruments1 – Imprecise tunnel length and geometry – Frequently require stromal hydration to seal – May result in cascading intraoperative difficulties (fluid control, anterior chamber maintenance) – Incisions may be unstable at low IOPs • Recent literature suggests an increased incidence of post-op infection2 Customized wound architecture and placement Self-sealing incisions 1Behrens A, Stark WJ, Pratzer KA, McDonnell PJ. Dynamics of small-incision clear cornea wounds after phacoemulsification surgery using optical coherence tomography in the early postoperative period, J Refract Surg, 2008;24(1):46-9. 2Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Sweet PM, McDonnell PJ. Acute endophthalmitis following cataract surgery: a LSX11513SK systematic review of the literature, Arch Ophthalmol. 2005;123(5):613-20. 12 Effective Lens Position (ELP) Does Capsulotomy Size Impact • “The key to highly accurate IOL power calculation is being able Effective Lens Position? 1 to correctly predict ELP for any given patient and IOL” • ELP is assumed value, from empirical data – A constant and surgeon factor • A significant source of IOL power error and key to post surgery refraction3 • Size of capsulorhexis effects ELP4 1Haigis W, Lege B, Miller N, Schneider B, Comparison of immersion ultrasound biometry and partial coherence interferometry for IOL calculation according to Haigis, Graefes, Arch Clin Exp Ophthalmol, 2000;238:765-773. 2Norrby S, Sources of error in intraocular lens power calculation,J Cataract Refract Surg, 2008;34:368-376. 3Hill WE, Does the Capsulorrhexis Affect Refractive Outcomes? In Chang D, editor: Cataract and Refractive Surgery Today, LSX11513SK 2009:78. 4Cekiç O, Batman C, The relationship between capsulorhexis size and anterior chamber depth relation. Ophthalmic Surg Lasers, 1999;30(3):185-190. Erratum in: Ophthalmic Surg Lasers,1999;30(9):714 13 4 11/16/2017 1 Factors Affecting IOL Predictability Laser Capsulotomy Results If IOL is 0.5 mm posterior to the If IOL is 0.5 mm anterior to the assumed plane, a 21 D lens will assumed plane, a 21 D lens will produce only 20 D of correction produce 22 D of correction Myopic Hyperopic • Perfect centration • Precision diameter: < ± 0.25 mm • No radial tears • Easy and complete removal of capsule • No adverse events • Less PCO formation 1Norrby S, Sources of error in intraocular lens power calculation,J Cataract Refract Surg, 2008;34:368-376. LSX11513SK 14 Laser Fragmentation • Cylinder pattern, utilized for the softer lens, enables removal with I & A only, no phaco power • Chop pattern efficiently fragments the lens for removal with reduced phaco power and time1 Only 20% of manual rhexis achieved diameter accuracy of +/- 0.25mm Astigmatism More Prevalent than Recognized Lane, Stephen, M.D. Toric IOLs Pearls for Success. Cataract & Refractive Surgery Today. August 2009. Pgs. 59-61. 5 11/16/2017 Addressing Astigmatism Basics of Corneal Incisions • Differentiate corneal • Corneal coupling – 1:1 ratio cylinder from refractive cylinder – Corneal • More flattening – Lenticular – Mixed – Larger incisions • Accurate / consistent – Central incisions measurements – Penetrating incisions – Manual keratometry – Corneal topography – Deeper cuts – IOL Master – Paired incisions – Lenstar – Cassini Arcuate Incisions Arcuate Incisions • Manually executed by “tracing” corneal marks with handheld diamond knife • Inconsistent depth control • Unpredictable effect due to imprecise wound architecture • Square edge and depth • Uniform depth (no ripples) • No image-guided surgical • Precise, reproducible planning or visualization – Arc shape – Arc length – Diameter LSX11513SK 20 Steinert RF, Application of the Femtosecond Laser in Cataract Surgery for the Creation of Multi-Planar, Self-Sealing Incisions, ASCRS 2010, Boston 22 Prediction Error Distribution Frequency Distribution (%) of Eyes Hyperopic Myopic 32% More 27%27% 23% Less 18% More Less LenSx… 15% 15% Manual… 12% 9% 9% 0% 0% 0% 5% 4% 0% 4% ≤ -1 -0.75 -0.5 -0.25 0 0.25 0.5 0.75 ≥ 1 LSX11513SK Spherical Equivalent Prediction Error (D) = Pred. Ref. - Actual 1M PostOP Ref. 27 6 11/16/2017 Femtosecond Laser Companies: Value Postoperative Considerations Added Indications • Normal postoperative course • Cataract Surgery: – One day – Anterior & Posterior Capsule Polishing – Posterior Capsulotomy – One week – Paracentesis –
Recommended publications
  • Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma
    Glaucoma Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma Jessica Tang,1,2 Flora Hui,1 Xavier Hadoux,1 Bernardo Soares,3 Michael Jamieson,3 Peter van Wijngaarden,1–3 Michael Coote,1–3 and Jonathan G. Crowston1,2,4,5 1Glaucoma Research Unit, Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia 2Ophthalmology, Department of Surgery, The University of Melbourne, Melbourne, Australia 3Royal Victorian Eye and Ear Hospital, Melbourne, Australia 4Centre for Vision Research, Duke-NUS Medical School, Singapore, Singapore 5Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore Correspondence: Jessica Tang, PURPOSE. To evaluate the short-term changes in inner retinal function using the photopic Glaucoma Research Unit, Centre for negative response (PhNR) after intraocular pressure (IOP) reduction in glaucoma. Eye Research Australia, Royal Victorian Eye and Ear Hospital, METHODS. Forty-seven participants with glaucoma who were commencing a new or addi- Level 7, Peter Howson Wing, 32 tional IOP-lowering therapy (treatment group) and 39 participants with stable glau- Gisborne St, East Melbourne, VIC coma (control group) were recruited. IOP, visual field, retinal nerve fiber layer thick- 3002, Australia; ness, and electroretinograms (ERGs) were recorded at baseline and at a follow-up visit [email protected]. (3 ± 2 months). An optimized protocol developed for a portable ERG device was used Received: August 29, 2019 to record the PhNR. The PhNR saturated amplitude (Vmax), Vmax ratio, semi-saturation Accepted: June 16, 2020 constant (K), and slope of the Naka–Rushton function were analyzed. Published: August 7, 2020 RESULTS.
    [Show full text]
  • Laser Learning Lecture and Lab: YAG Caps, LPI, And
    5/9/17 Overview Laser Learning Lecture and Lab: • Why we use lasers YAG caps, LPI, and SLT • YAG capsulotomy • Laser Peripheral Iridotomy (LPI or PI) Aaron McNulty, O.D., F.A.A.O. • Argon Laser Peripheral Iridoplasty (ALPI) Nate Lighthizer, O.D., F.A.A.O. • Argon Laser Trabeculoplasty (ALT) • Selective Laser Trabeculoplasty (SLT) • Other Laser Trabeculoplasty Why do we use lasers? Posterior Capsular Opacification (PCO) • Vision is decreased from PCO following cataract surgery • Lens capsular bag has an anterior and • Narrow angles/angle closure posterior surface • Glaucoma is progressing in a pt on max meds – Anterior surface usually removed w/ capsulorhexis – Something else needs to be done – Surgery not wanted yet • PCO is the formation of a cloudy membrane • Compliance issues on the posterior surface of the capsular bag • Cost issues following ECCE • Convenience issues – AKA: Secondary cataract • Doctor preference PCO YAG Laser • Incidence: • Nd: YAG laser – Most common complication of post ECCE – Neodymium: Yttrium aluminum garnet laser – 10-80% of eyes following cataract surgery – Can form anywhere from a few days to years post surgery • Tissue interaction: Photodisruptive laser – Younger patients higher risk of PCO – High light energy levels cause the tissues to be reduced – IOL’s to plasma, disintegrating the tissue • Silicone > acrylic – A large amount of energy is delivered into very small focal spots in a very brief duration of time • Prevention: • 4 nsec – – Capsulotomy during surgery No thermal reaction/No coagulation when bv’s are hit – Posterior capsular polishing – Pigment independent* 1 5/9/17 YAG Cap Risks, Complications, YAG Cap Pre-op Exam Contraindications • Visual acuity, glare testing, PAM/Heine lambda Contraindications Risks/complications – Vision 20/30 or worse 1.
    [Show full text]
  • Laser Procedures for the Management of Glaucoma and More Handout
    4/25/17 Overview Laser Procedures for the Management • Why we use lasers of Glaucoma and More • YAG capsulotomy Nate Lighthizer, O.D., F.A.A.O. • Laser Peripheral Iridotomy (LPI or PI) Assistant Professor, NSUOCO • Argon Laser Peripheral Iridoplasty (ALPI) Assistant Dean, Clinical Care Services • Argon Laser Trabeculoplasty (ALT) Director of CE Chief of Specialty Care Clinics • Selective Laser Trabeculoplasty (SLT) Chief of Electrodiagnostics Clinic • Other Laser Trabeculoplasty [email protected] Why do we use lasers? Posterior Capsular Opacification (PCO) • Vision is decreased from PCO following cataract surgery • Lens capsular bag has an anterior and • Narrow angles/angle closure posterior surface • Glaucoma is progressing in a pt on max meds – Anterior surface usually removed w/ capsulorhexis – Something else needs to be done – Surgery not wanted yet • PCO is the formation of a cloudy membrane • Compliance issues on the posterior surface of the capsular bag • Cost issues following ECCE • Convenience issues – AKA: Secondary cataract • Doctor preference PCO YAG Laser • Incidence: • Nd: YAG laser – Most common complication of post ECCE – Neodymium: Yttrium aluminum garnet laser – 10-80% of eyes following cataract surgery – Can form anywhere from a few days to years post surgery • Tissue interaction: Photodisruptive laser – Younger patients higher risk of PCO – High light energy levels cause the tissues to be reduced – IOL’s to plasma, disintegrating the tissue • Silicone > acrylic – A large amount of energy is delivered into very small focal spots in a very brief duration of time • Prevention: • 4 nsec – – Capsulotomy during surgery No thermal reaction/No coagulation when bv’s are hit – Posterior capsular polishing – Pigment independent* 1 4/25/17 YAG Cap Risks, Complications, YAG Cap Pre-op Exam Contraindications • Visual acuity, glare testing, PAM/Heine lambda Contraindications Risks/complications – Vision 20/30 or worse 1.
    [Show full text]
  • Bjophthalmol-2020-318090 1..2
    At a glance Br J Ophthalmol: first published as 10.1136/bjophthalmol-2020-318090 on 26 October 2020. Downloaded from Highlights from this issue doi:10.1136/bjophthalmol-2020-318090 Keith Barton , James Chodosh , Jost B Jonas , Editors in chief Glaucoma in the Northern Ireland Cohort The effect of partial posterior vitreous Comparison of OCT angiography in for the Longitudinal Study of Ageing detachment on spectral-domain optical children with a history of intravitreal (NICOLA): cohort profile, prevalence, coherence tomography retinal nerve fibre injection of ranibizumab vs laser awareness and associations (seepage1492) layer thickness measurements photocoagulation for retinopathy of The crude prevalence of glaucoma in (seepage1524) prematurity (see page 1556) Northern Ireland of 2.83% (95% CI Among glaucoma suspects, eyes with par- In this cross-sectional study, we found that 2.31%, 3.46%) is comparable to other tial posterior vitreous detachments, com- the central foveal vessel length density and European population-based studies. pared to eyes without, were associated perfusion density, the foveal avascular Approximately two thirds of people with with greater average, superior, and inferior zone area and central foveal thicknesses glaucoma were undiagnosed. Associations retinal nerve fibre layer thickness of children who had undergone different with glaucoma were consistent with cur- measurements. treatments, might vary. rent understanding of the disease. Three-year follow-up of choroidal Comparison of central visual sensitivity Selective
    [Show full text]
  • A Review of Selective Laser Trabeculoplasty: Recent Findings and Current Perspectives
    Ophthalmol Ther DOI 10.1007/s40123-017-0082-x REVIEW A Review of Selective Laser Trabeculoplasty: Recent Findings and Current Perspectives Yujia Zhou . Ahmad A. Aref Received: January 17, 2017 Ó The Author(s) 2017. This article is published with open access at Springerlink.com ABSTRACT explored, revealing that minor modifications may lead to a more favorable or safer clinical Selective laser trabeculoplasty (SLT) has been outcome. The utilization of postoperative widely used in the clinical management of medications remains controversial based on the glaucoma, both as primary and adjunctive current evidence. A short-term IOP increase treatment. As new evidence continues to arise, may complicate SLT and can also persist in we review the current literature in terms of certain cases such as in exfoliation glaucoma. indications and efficacy, surgical technique, The efficacy and safety of repeat SLT are shown postoperative care, repeatability, and compli- in multiple studies, and the timing of repeat cations of this therapy. SLT has been shown to procedures may affect the success rate. be effective in various glaucomas, including primary open-angle glaucoma (POAG), nor- mal-tension glaucoma (NTG), steroid-induced Keywords: Glaucoma; Intraocular pressure; glaucoma, pseudoexfoliation glaucoma (PXFG), Laser; Selective laser trabeculoplasty and primary angle-closure glaucoma (PACG), as well as other glaucoma subtypes. Relatively high preoperative intraocular pressure (IOP) INTRODUCTION may predict surgical success, while other parameters that have been studied do not seem Intraocular pressure (IOP) reduction is the to affect the outcome. Different techniques for mainstay of therapy for glaucomatous optic performing the procedure have recently been neuropathy. Selective laser trabeculoplasty (SLT) has been widely employed for this pur- Enhanced content To view enhanced content for this pose over the past several years as both a pri- article go to http://www.medengine.com/Redeem/ mary and adjunctive treatment [1].
    [Show full text]
  • LCD): Computerized Corneal Topography (L33810
    Local Coverage Determination (LCD): Computerized Corneal Topography (L33810) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information CONTRACTOR NAME CONTRACT TYPE CONTRACT NUMBER JURISDICTION STATE(S) First Coast Service Options, Inc. A and B MAC 09102 - MAC B J - N Florida First Coast Service Options, Inc. A and B MAC 09202 - MAC B J - N Puerto Rico First Coast Service Options, Inc. A and B MAC 09302 - MAC B J - N Virgin Islands LCD Information Document Information LCD ID Original Effective Date L33810 For services performed on or after 10/01/2015 LCD Title Revision Effective Date Computerized Corneal Topography For services performed on or after 01/08/2019 Proposed LCD in Comment Period Revision Ending Date N/A N/A Source Proposed LCD Retirement Date N/A N/A AMA CPT / ADA CDT / AHA NUBC Copyright Notice Period Start Date Statement N/A CPT codes, descriptions and other data only are copyright 2019 American Medical Association. All Rights Notice Period End Date Reserved. Applicable FARS/HHSARS apply. N/A Current Dental Terminology © 2019 American Dental Association. All rights reserved. Copyright © 2019, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB-04 codes and descriptions may not be removed, copied, or utilized within any Created on 01/02/2020. Page 1 of 7 software, product, service, solution or derivative work without the written consent of the AHA.
    [Show full text]
  • Laser Trabeculoplasty for Open-Angle Glaucoma a Report by the American Academy of Ophthalmology
    Laser Trabeculoplasty for Open-Angle Glaucoma A Report by the American Academy of Ophthalmology John R. Samples, MD,1 Kuldev Singh, MD, MPH,2 Shan C. Lin, MD,3 Brian A. Francis, MD,4 Elizabeth Hodapp, MD,5 Henry D. Jampel, MD, MHS,6 Scott D. Smith, MD, MPH7 Objective: To provide an evidence-based summary of the outcomes, repeatability, and safety of laser trabeculoplasty for open-angle glaucoma. Methods: A search of the peer-reviewed literature in the PubMed and the Cochrane Library databases was conducted in June 2008 and was last repeated in March 2010 with no date or language restrictions. The search yielded 637 unique citations, of which 145 were considered to be of possible clinical relevance for further review and were included in the evidence analysis. Results: Level I evidence indicates an acceptable long-term efficacy of initial argon laser trabeculoplasty for open-angle glaucoma compared with initial medical treatment. Among the remaining studies, level II evidence supports the efficacy of selective laser trabeculoplasty for lowering intraocular pressure for patients with open-angle glaucoma. Level III evidence supports the efficacy of repeat use of laser trabeculoplasty. Conclusions: Laser trabeculoplasty is successful in lowering intraocular pressure for patients with open- angle glaucoma. At this time, there is no literature establishing the superiority of any particular form of laser trabeculoplasty. The theories of action of laser trabeculoplasty are not elucidated fully. Further research into the differences among the lasers used in trabeculoplasty, the repeatability of the procedure, and techniques of treatment is necessary. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.
    [Show full text]
  • Objective Assessment of Retinal Ganglion Cell Function in Glaucoma
    Objective Assessment of Retinal Ganglion Cell Function in Glaucoma Submitted by Nabin R. Joshi DISSERTATION In partial satisfaction of the requirements for the degree of Doctor of Philosophy SUNY College of Optometry (September 25th, 2017) 1 Abstract Background Glaucoma refers to a group of diseases causing progressive degeneration of the retinal ganglion cells. It is a clinical diagnosis based on the evidence of structural damage of the optic nerve head with corresponding visual field loss. Structural damage is assessed by visualization of the optic nerve head (ONH) through various imaging and observational techniques, while the behavioral loss of sensitivity is assessed with an automated perimeter. However, given the subjective nature of visual field assessment in patients, visual function examination suffers from high variability as well as patient and operator- related biases. To overcome these drawbacks, past research has focused on the use of objective methods of quantifying retinal function in patients with glaucoma such as electroretinograms, visually evoked potentials, pupillometry etc. Electroretinograms are objective, non-invasive method of assessing retinal function, and careful manipulation of the visual input or stimulus can result in extraction of signals particular to select classes of the retinal cells, and photopic negative response (PhNR) is a component of ERG that reflects primarily the retinal ganglion cell function. On the other hand, pupillary response to light, measured objectively with a pupillometer, also indicates the functional state of the retina and the pupillary pathway. Hence, the study of both ERGs and pupillary response to light provide an objective avenue of research towards understanding the mechanisms of neurodegeneration in glaucoma, possibly affecting the clinical care of the patients in the long run.
    [Show full text]
  • Glaucoma Comanagement: Surgical
    6/27/2017 Virginia Eye Consultants Tertiary Referral Eye Care Since 1963 • John D. Sheppard, MD, MMSc • Walter O. Whitley, OD, MBA, FAAO Innovations in Glaucoma • Stephen V. Scoper, MD • Mark Enochs, OD • David Salib, MD • Cecelia Koetting, OD, FAAO COPE#52116-GL • Elizabeth Yeu, MD • Christopher Kuc, OD • Thomas J. Joly, MD, PhD • Leanna Olennikov, OD • Dayna M. Lago, MD • Jillian Janes, OD • Constance Okeke, MD, MSCE Walter O. Whitley, OD, MBA, FAAO • Esther Chang, MD Director of Optometric Services • Jay Starling, MD Virginia Eye Consultants • Samantha Dewundara, MD Residency Program Supervisor • Surajit Saha, MD Pennsylvania College of Optometry Disclosures Walter O. Whitley, OD, MBA, FAAO has received consulting fees, honorarium or research funding from: • Alcon • Diopsys • Allergan • Ocusoft • Bausch and Lomb • Science Based Health • Biotissue • Shire • Beaver-Visitec • TearLab Corporation • Publications – Advanced Ocular Care – Co-Chief Medical Editor – Review of Optometry – Contributing Editor – Optometry Times – Editorial Advisory Board The Most Valuable Glaucoma Tool Glaucoma: Diagnosis • We know it when we see it IOP: 26 OU 1 6/27/2017 Glaucoma Diagnosis Glaucoma Diagnosis • Gonioscopy • Central corneal thickness • Visual fields • Fundus photography • Scanning lasers • Serial tonometry • Electrodiagnositics – VEP / PERG GLAUCOMA SEVERITY SCALE Managing Glaucoma Patients DEFINITIONS • Mild Stage: optic nerve changes consistent with glaucoma but • Monitor IOP reduction: 1-2 week, 1 month NO visual field abnormalities on any visual field test OR abnormalities present only on short-wavelength automated • Check IOP every 3-4 months perimetry or frequency doubling perimetry. • Repeat VF every 6-12 months • Moderate Stage: optic nerve changes consistent with • Disc photos every 1-2 years glaucoma AND glaucomatous visual field abnormalities in one hemifield and not within 5 degrees of fixation.
    [Show full text]
  • Division of Health Care Financing & Policy SB 278 Section 16
    Division of Health Care Financing & Policy SB 278 Section 16 - Physician Rates Reporting Facility & Non-Facility Rate Comparison Nevada 2016 2016 Medicaid Medicaid Medicaid Medicare Medicare vs. vs. Procedure Code & Description Rates (1) Non-Facility Facility Medicare Medicare Rates for Rates for Non-Facility Facility 10021 Fna w/o image 70.92 128.90 72.80 (57.98) (1.88) 10022 Fna w/image 65.39 148.21 68.38 (82.82) (2.99) 10030 Guide cathet fluid drainage 154.73 827.01 176.71 (672.28) (21.98) 10035 Perq dev soft tiss 1st imag 86.35 568.38 90.92 (482.03) (4.57) 10036 Perq dev soft tiss add imag 43.52 495.42 45.82 (451.90) (2.30) 10040 Acne surgery 87.47 106.03 92.10 (18.56) (4.63) 10060 Drainage of skin abscess 95.60 122.68 101.60 (27.08) (6.00) 10061 Drainage of skin abscess 178.04 215.50 188.01 (37.46) (9.97) 10080 Drainage of pilonidal cyst 103.29 188.83 107.87 (85.54) (4.58) 10081 Drainage of pilonidal cyst 172.45 281.57 177.64 (109.12) (5.19) 10120 Remove foreign body 103.22 159.56 108.73 (56.34) (5.51) 10121 Remove foreign body 185.58 287.08 194.44 (101.50) (8.86) 10140 Drainage of hematoma/fluid 118.06 170.87 124.18 (52.81) (6.12) 10160 Puncture drainage of lesion 95.62 136.49 100.72 (40.87) (5.10) 10180 Complex drainage wound 178.97 258.94 188.14 (79.97) (9.17) 11000 Debride infected skin 28.42 56.88 29.76 (28.46) (1.34) 11001 Debride infected skin add-on 14.22 22.40 14.87 (8.18) (0.65) 11004 Debride genitalia & perineum 579.35 608.28 608.28 (28.93) (28.93) 11005 Debride abdom wall 781.65 822.97 822.97 (41.32) (41.32) 11006 Debride
    [Show full text]
  • Current Developments in Corneal Topography and Tomography
    diagnostics Review Current Developments in Corneal Topography and Tomography Piotr Kanclerz 1,2,* , Ramin Khoramnia 3 and Xiaogang Wang 4 1 Hygeia Clinic, Department of Ophthalmologyul, Ja´skowaDolina 57, 80-286 Gda´nsk,Poland 2 Helsinki Retina Research Group, University of Helsinki, 00100 Helsinki, Finland 3 The David J. Apple International Laboratory for Ocular Pathology, Department of Ophthalmology, University of Heidelberg, 69120 Heidelberg, Germany; [email protected] 4 Department of Cataract, Shanxi Eye Hospital, Taiyuan 030002, China; [email protected] * Correspondence: [email protected] Abstract: Introduction: Accurate assessment of the corneal shape is important in cataract and refractive surgery, both in screening of candidates as well as for analyzing postoperative outcomes. Although corneal topography and tomography are widely used, it is common that these technologies are confused. The aim of this study was to present the current developments of these technologies and particularly distinguish between corneal topography and tomography. Methods: The PubMed, Web of Science and Embase databases were the main resources used to investigate the medical literature. The following keywords were used in various combinations: cornea, corneal, topography, tomography, Scheimpflug, Pentacam, optical coherence tomography. Results: Topography is the study of the shape of the corneal surface, while tomography allows a three-dimensional section of the cornea to be presented. Corneal topographers can be divided into large- and small-cone Placido-based devices, as well as devices with color-LEDs. For corneal tomography, scanning slit or Scheimpflug imaging and optical coherence tomography may be employed. In several devices, corneal topography and tomography have been successfully combined with tear-film analysis, aberrometry, optical biometry and anterior/posterior segment optical coherence tomography.
    [Show full text]
  • Safety and Effectiveness of the UV-X System for Corneal Collagen Cross
    Evaluation of two Riboflavin Dosing Regimens for Corneal Collagen Cross-Linking in Eyes with Progressive Keratoconus or Ectasia Protocol 2010-0243, Version: 15 Protocol Date: September 16, 2016 PHYSICIAN SPONSOR: Francis W. Price, Jr. MD CONFIDENTIAL Background This clinical protocol is designed to evaluate two riboflavin-dosing regimens for treatment of patients with progressive keratoconus or corneal ectasia using investigational technology that increases the cross linking of the corneal stroma using the photochemical interaction of UVA light with the chromophore riboflavin. In this treatment, the corneal stroma is saturated with riboflavin by irrigating the surface after removal of the corneal epithelium. The riboflavin-saturated cornea is then exposed to a uniform field of UVA light with a narrow bandwidth centered at 365 nm. The light is generated by an IROC UV-X irradiation system that creates a uniform 11 mm circle of UVA light. The device has a timer that allows a precise 30-minute exposure of the corneal tissues. The irradiation field of the UVX system produces UVA light with a uniform irradiance of 3 mj/cm2 at the corneal surface. The FDA has classified this technology as a combination product with two components. First is the UV-X light source, which has an LED source and is calibrated and rendered uniform by the use of an optical homogenizer. The second component is a riboflavin ophthalmic solution. This solution is used to saturate the corneal stroma prior to its photochemical activation. This combination product has been studied in a FDA-approved, randomized, placebo- controlled, multi-center trial that has enrolled patients.
    [Show full text]